MRNA
Moderna, Inc.
- Selling, general and administrative, Q3 2026
- $282M
- YoY, Q3 2026
- +5.2%
Selling, general and administrative
Selling, general and administrative by quarter
| Period | SG&A | YoY |
|---|---|---|
| Q3 2026 | $282M | +5.2% |
| Q3 2025 | $268M | — |
Moderna, Inc.
| Period | SG&A | YoY |
|---|---|---|
| Q3 2026 | $282M | +5.2% |
| Q3 2025 | $268M | — |